The Technology

 

LapIQ's proprietary biodegradable platform solutions were initially developed for laparoscopic trocar port closure and repair of congenital abdominal wall defects. The company has built a substantial patent library around individualized scaffold designs.

 

LAP IQ Inc. is currently operating in stealth mode.

LapIQ is backed by a medical advisory board of general surgeons from Stanford University and University of California, San Francisco.